These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

429 related items for PubMed ID: 15507213

  • 1. JunB deficiency leads to a myeloproliferative disorder arising from hematopoietic stem cells.
    Passegué E, Wagner EF, Weissman IL.
    Cell; 2004 Oct 29; 119(3):431-43. PubMed ID: 15507213
    [Abstract] [Full Text] [Related]

  • 2. [Loss of junB expression causes a myeloproliferative syndrome resembling chronic myeloid leukemia].
    Jochum W, Passegue E, Wagner EF.
    Verh Dtsch Ges Pathol; 1999 Oct 29; 83():216-7. PubMed ID: 10714213
    [Abstract] [Full Text] [Related]

  • 3. Selective activation of STAT5 unveils its role in stem cell self-renewal in normal and leukemic hematopoiesis.
    Kato Y, Iwama A, Tadokoro Y, Shimoda K, Minoguchi M, Akira S, Tanaka M, Miyajima A, Kitamura T, Nakauchi H.
    J Exp Med; 2005 Jul 04; 202(1):169-79. PubMed ID: 15998795
    [Abstract] [Full Text] [Related]

  • 4. Lhx2 expression in hematopoietic progenitor/stem cells in vivo causes a chronic myeloproliferative disorder and altered globin expression.
    Richter K, Pinto do O P, Hägglund AC, Wahlin A, Carlsson L.
    Haematologica; 2003 Dec 04; 88(12):1336-47. PubMed ID: 14687986
    [Abstract] [Full Text] [Related]

  • 5. Role of SPA-1 in phenotypes of chronic myelogenous leukemia induced by BCR-ABL-expressing hematopoietic progenitors in a mouse model.
    Kometani K, Aoki M, Kawamata S, Shinozuka Y, Era T, Taniwaki M, Hattori M, Minato N.
    Cancer Res; 2006 Oct 15; 66(20):9967-76. PubMed ID: 17047059
    [Abstract] [Full Text] [Related]

  • 6. JunB protects against myeloid malignancies by limiting hematopoietic stem cell proliferation and differentiation without affecting self-renewal.
    Santaguida M, Schepers K, King B, Sabnis AJ, Forsberg EC, Attema JL, Braun BS, Passegué E.
    Cancer Cell; 2009 Apr 07; 15(4):341-52. PubMed ID: 19345332
    [Abstract] [Full Text] [Related]

  • 7. Increased c-Myc activity and DNA damage in hematopoietic progenitors precede myeloproliferative disease in Spa-1-deficiency.
    Tanaka H, Tamura A, Sekai M, Hamazaki Y, Minato N.
    Cancer Sci; 2011 Apr 07; 102(4):784-91. PubMed ID: 21205094
    [Abstract] [Full Text] [Related]

  • 8. Miscreant myeloproliferative disorder stem cells.
    Jamieson CH, Barroga CF, Vainchenker WP.
    Leukemia; 2008 Nov 07; 22(11):2011-9. PubMed ID: 18923436
    [Abstract] [Full Text] [Related]

  • 9. Constitutive activation of Flt3 and STAT5A enhances self-renewal and alters differentiation of hematopoietic stem cells.
    Moore MA, Dorn DC, Schuringa JJ, Chung KY, Morrone G.
    Exp Hematol; 2007 Apr 07; 35(4 Suppl 1):105-16. PubMed ID: 17379095
    [Abstract] [Full Text] [Related]

  • 10. WNT proteins: environmental factors regulating HSC fate in the niche.
    Luis TC, Staal FJ.
    Ann N Y Acad Sci; 2009 Sep 07; 1176():70-6. PubMed ID: 19796234
    [Abstract] [Full Text] [Related]

  • 11. Activation of quiescent ABL-transduced hemopoietic stem cells.
    Chung SW, Chen H, Wong PM.
    Oncogene; 1996 Dec 05; 13(11):2397-405. PubMed ID: 8957081
    [Abstract] [Full Text] [Related]

  • 12. c-Jun and JunB are essential for hypoglycemia-mediated VEGF induction.
    Textor B, Sator-Schmitt M, Richter KH, Angel P, Schorpp-Kistner M.
    Ann N Y Acad Sci; 2006 Dec 05; 1091():310-8. PubMed ID: 17341624
    [Abstract] [Full Text] [Related]

  • 13. Targeting c-Jun and JunB proteins as potential anticancer cell therapy.
    Gurzov EN, Bakiri L, Alfaro JM, Wagner EF, Izquierdo M.
    Oncogene; 2008 Jan 24; 27(5):641-52. PubMed ID: 17667939
    [Abstract] [Full Text] [Related]

  • 14. Nitric oxide differentially regulates proliferation and mobilization of endothelial progenitor cells but not of hematopoietic stem cells.
    Ozüyaman B, Ebner P, Niesler U, Ziemann J, Kleinbongard P, Jax T, Gödecke A, Kelm M, Kalka C.
    Thromb Haemost; 2005 Oct 24; 94(4):770-2. PubMed ID: 16270628
    [Abstract] [Full Text] [Related]

  • 15. Etiology of the myeloproliferative disorders: the role of thrombopoietin.
    Kaushansky K.
    Semin Hematol; 2003 Jan 24; 40(1 Suppl 1):6-9. PubMed ID: 12682875
    [Abstract] [Full Text] [Related]

  • 16. Bone marrow connexin-43 expression is critical for hematopoietic regeneration after chemotherapy.
    Presley CA, Lee AW, Kastl B, Igbinosa I, Yamada Y, Fishman GI, Gutstein DE, Cancelas JA.
    Cell Commun Adhes; 2005 Jan 24; 12(5-6):307-17. PubMed ID: 16531325
    [Abstract] [Full Text] [Related]

  • 17. c-Myc is essential for hematopoietic stem cell differentiation and regulates Lin(-)Sca-1(+)c-Kit(-) cell generation through p21.
    Baena E, Ortiz M, Martínez-A C, de Alborán IM.
    Exp Hematol; 2007 Sep 24; 35(9):1333-43. PubMed ID: 17637497
    [Abstract] [Full Text] [Related]

  • 18. Jun signalling in the epidermis: From developmental defects to psoriasis and skin tumors.
    Zenz R, Wagner EF.
    Int J Biochem Cell Biol; 2006 Sep 24; 38(7):1043-9. PubMed ID: 16423552
    [Abstract] [Full Text] [Related]

  • 19. Chronic myeloid leukemia with increased granulocyte progenitors in mice lacking junB expression in the myeloid lineage.
    Passegué E, Jochum W, Schorpp-Kistner M, Möhle-Steinlein U, Wagner EF.
    Cell; 2001 Jan 12; 104(1):21-32. PubMed ID: 11163237
    [Abstract] [Full Text] [Related]

  • 20. Shp-2 heterozygous hematopoietic stem cells have deficient repopulating ability due to diminished self-renewal.
    Chan RJ, Li Y, Hass MN, Walter A, Voorhorst CS, Shelley WC, Yang Z, Orschell CM, Yoder MC.
    Exp Hematol; 2006 Sep 12; 34(9):1230-9. PubMed ID: 16939816
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.